При пациенти с чернодробно или бъбречно увреждане нуждите от инсулин могат да бъдат намалени.
Long-term safety of inhaled human insulin has not been established in paediatric patients with diabetes and its use is therefore not recommended in patients under 18 years of age (see section 5.2).